Retroviral gene transfer into cord blood stem/progenitor cells using purified vector stocks

American Journal of Hematology

Volumn 57, Issue 1, 1998, Pages 16-23

  Asch, Julie ^a   Weinberg, Rona S ^b   Mueller, Lisa ^b   Galperin, Yelena ^b   Kiang, Lily ^b   Jolly, Douglas ^c   Isola, Luis M ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Gene therapy; Hematopoietic stem cell; Retrovirus; Umbilical cord blood

Indexed keywords

CD34 ANTIGEN; VIRUS VECTOR;

ARTICLE; BONE MARROW TRANSPLANTATION; COLONY FORMATION; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER; HEMATOPOIESIS; HUMAN; HUMAN CELL; INFECTION RATE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REPORTER GENE; RETROVIRUS; STEM CELL; TARGET CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BETA-GALACTOSIDASE; CELL SEPARATION; CELLS, CULTURED; FETAL BLOOD; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; METHODS; POLYAMINES; RETROVIRIDAE; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 0031984855     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199801)57:1<16::AID-AJH3>3.0.CO;2-4     Document Type: Article

References (53)

1. Williams DA, Lemischka IR, Nathan DG, Mulligan RC: Introduction of new genetic material into pluripotent stem cells of the mouse. Nature 310:476-480, 1984.
2. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481-2492, 1991.
3. Kohn DB: The current status of gene therapy using hematopoietic stem cells. Curr Opin Pediatr 7:56-63, 1995.
4. Markowitz D, Goff S, Bank A: Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400-406, 1988.
5. Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture initiating cells. Blood 79:1393-1399, 1992.
6. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency. J Exp Med 178:529-536, 1993.
7. Crooks G, Kohn D: Growth factors increase amphotropic retrovirus binding to human CD34+ bone marrow progenitor cells. Blood 82: 3290-3297, 1993.
8. Hanley ME, Nolta JA, Parkman R, Kohn D: Umbilical cord blood cell transduction by retroviral vectors: Preclinical studies to optimize gene transfer. Blood Cells 20:539-543, 1994.
9. Williams DA, Moritz T: Umbilical cord blood stem cells as targets for genetic modification: New therapeutic approaches to somatic gene therapy. Blood Cells 20:504-515, 1994.
10. v mice. Cell 42:71-79, 1985.
11. Chertkov JL, Jiang S, Lutton JD, Harrison J, Levere RD, Tiefenthaler M, Abraham NG: The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells. Stem Cells 11:218-227, 1993.
12. Szilvassy S, Cory S: Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84:74-83, 1994.
13. Qazilbash MH, Walsh CE, Russell SM, Noguchi M, Mann MM, Leonard WJ, Liu JM: Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome. J Hematother 4:91-98, 1995.
14. Stead RB, Kwok WW, Storb R, Miller AD: Canine model for gene therapy: Inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors. Blood 71:742-747, 1988.
15. Carter RF, Abrams-Ogg ACG, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID: Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79: 356-364, 1991.
16. Bienzle D, Abrams-Ogg ACG, Kruth SA, Ackland-Snow J, Carter RF, Dick JE, Jacobs RM, Kamel-Reid S, Dube ID: Gene transfer into hematopoietic stem cells: Long term maintenance of in vitro activated progenitors without marrow ablation. Proc Natl Acad Sci USA 91: 350-354, 1994.
17. Kiem HP, Darovsky B, von Kalle C, Goehle S, Stewart D, Graham T, Hackman R, Appelbaum F, Deeg J, Miller AD, Storb R, Schuening FG: Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 83:1467-1473, 1994.
18. van Beusechem VW, Bakx T, Kaptein LCM, Bart-Baumeister JAK, Kukler A, Braakman E, Valerio D: Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: The effect of viral titers on transduction efficiency. Hum Gene Ther 4:239-247, 1993.
19. Bodine DM, Moritz T, Donahue RE, Luskey BD, Kessler SW, Martin DIK, Orkin SH, Nienhuis AW, Williams DA: Long term expression of murine adenosine deaminase (ADA) gene in rhesus multilineage hematopoietic cells following retroviral mediated gene transfer into CD34+ bone marrow cells. Blood 82:1975-1980, 1993.
20. Blaese RM, Culver KW, Chang L, Anderson WE, Mullen C, Neinhuis A, Kobyashi R, Kobyashi AL, Klein H, Shearer G, Clerici M, McGarrity G, Cassell A: Treatment of severe combined immunodeficiency (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Hum Gene Ther 4:521-527, 1993.
21. Hoogerbrugge PM, von Beusechem VW, Kaptein LC, Einerhand MP, Valerio D: Gene therapy for adenosine deaminase deficiency. Br Med Bull 51:72-81, 1995.
22. Kohn D, Weinberg K, Nolta J, Heiss L, Lenarsky C, Crooks G, Hanely M, Annett G, Brooks J, El-Khoureiy A, Lawrence K, Wells S, Moen R, Bastian T, Hershfield M, Mullen C, Blaese R, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1:1017-1023, 1995.
23. Etkin M, Filaccio M, Ellerson D, Sun SP, Claxton D, Gaozza E, Brenner M, Moen R, Belmont J, Moore K, Mosely AM, Reading C, Khouri I, Talpaz M, Kantarjian H, Deisseroth A: Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals. Hum Gene Ther 3:137-145, 1992.
24. Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J, Krance RA, Ihle JN, Brenner MK: An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplan- talion using retrovirus-mediated gene transfer. Blood 79:2694-2700, 1992.
25. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN: Gene marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85-86, 1993.
26. Shi YJ, Shen RN, Lu L, Broxmeyer HE: Comparative analysis of retroviral-mediated gene transduction into CD34+ cord blood hematopoietic progenitors in the presence and absence of growth factors. Blood Cells 20:517-524, 1994.
27. Hughes PF, Thacker JD, Hogge D, Sutherland HJ, Thomas TE, Lansdorp PM, Eaves CJ, Humphries RK: Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest 89:1817-1824, 1992.
28. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239-4242, 1990.
29. DeBruyn C, Delforge A, Bron D, Bernier M, Massy M, Ley R, de Hemptinne D, Stryckmans P: Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on the CD34 purified cells from human cord blood and bone marrow. Stem Cells 13:281-288, 1995.
30. Payne TA, Traycoff CM, Laver J, Xu F, Srour EF, Abboud MR: Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors-relevance to cord blood stem cell transplantation. Bone Marrow Trans 15:187-192, 1995.
31. Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE: High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089-2096, 1993.
32. Bertolini F, de Monte L, Corsini C, Lazzari L, Lauri E, Soligo D, Ward M, Bank A, Malavasi F: Retrovirus-mediated transfer of the multidrug resistance gene into human haemopoietic progenitor cells. Br J Hematol 88:318-324, 1994.
33. Mannion-Henderson J, Kemp A, Mohney T, Nimgaonkar M, Lancia J, Beeler MT, Mierski J, Bahnson AB, Ball ED, Barranger JA: Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors. Exp Hematol 23:1628-1632, 1995.
34. Yu M, Leavitt MC, Maruyama M, Yamada O, Young D, Ho AD, Wong-Staal F: Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 92:699-703, 1995.
35. Lu L, Ge Y, Li ZH, Xiao M, Broxmeyer HE: Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33 or low cord blood cells on cytokine-stimulated erythroid colony formation. Exp Hematol 24:347-351, 1996.
36. Apperley JF: Umbilical cord blood progenitor cell transplantation. The International Conference Workshop on cord blood transplantation. Bone Marrow Trans 14:187-196, 1994.
37. Wagner JE: Umbilical cord blood transplantation: Overview of the clinical experience. Blood Cells 20:227-234, 1994.
38. Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P: The use of umbilical cord blood in mismatched related and unrelated hematopoietic stem cell transplantation. Blood Cells 20:275-284, 1994.
39. Wagner JE, Kernan NA, Steinbach M, Broxmeyer HE, Gluckman E: Allogeneic sibling umbilical cord blood transplantation in children with malignant and nonmalignant disease. Lancet 346:214-219, 1995.
40. Weinberg RS, Goldberg JD, Schofield JM, Lenes AL, Styczynski R, Alter BP: Switch from fetal to adult hemoglobin is associated with a change in progenitor cell population. J Clin Invest 71:785-794, 1983.
41. Weinberg RS, Thomson JC, Lao R, Chen G, Alter BP: Stem cell factor (SCF) amplifies newborn and sickle erythropoiesis in liquid cultures. Blood 81:2591-2599 (and cover photograph), 1993.
42. Irwin MJ, Laube LS, Lee V, Austin M, Chada S, Anderson CG, Townsend K, Jolly DJ, Warner JF: Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and non-human primates. J Virol 68:5036-5044, 1994.
43. Podda S, Ward M, Himelstein A, Richardson C, DeLaFlor-Weiss E, Smith L, Gottesman, M, Pastan I, Bank A: Transfer and expression of the human multiple resistance gene into live mice. Proc Natl Acad Sci USA 89:9676-9680, 1992.
44. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517, 1975.
45. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE: Stored placental blood for unrelated bone marrow reconstitution. Blood 81: 1679-1690, 1993.
46. Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein R, Bard J, Boyse EA: Collection, separation, and crypreservation of umbilical cord blood for use in transplantation. Bone Marrow Trans 13:135-143, 1994.
47. Onifer SM, White LA, Whittemore SR, Holets VR: In vitro labeling strategies for identifying primary neural tissue and a neuronal cell line after transplantation in the CNS. Cell Transplant 2:131-149, 1993.
48. Tong J, Hoffman R, Siena S, Srour EF, Bregni M, Gianni AM: Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts. Exp Hematol 22:1016-1024, 1994.
49. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Sci 267:104-108, 1995.
50. Cornetta K, Anderson WF: Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene transfer: Implications for human gene therapy. J Virol Methods 23:187-194, 1989.
51. Flasshove M, Banerjee D, Mineishi M, Li MX, Bertino JR, Moore MAS: Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85:566-574, 1995.
52. Lu L, Xiao M, Shen R-N, Grigsby S, Broxmeyer HE: Enrichment, characterization, and responsiveness of single primitive CD34+ and human umbilical cord blood hematopoietic progenitor cells with high proliferative and replating potential. Blood 81:41-48, 1993.
53. Carow CE, Hangoc G, Broxmeyer HE: Human multipotential progenitor cell (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma. Blood 81: 942-949, 1993.